Previously Treated Advanced-Disease NSCLC KRAS G12C From a Canadian Multi-Institutional Real-World Evidence Database (CARMA)

被引：0

作者：

Zhan, L. J. ^{[1
]}

Barghout, S. ^{[1
]}

Raptis, S. ^{[1
]}

Al-Agha, F. ^{[1
]}

Popovacki, A. ^{[2
]}

Esfahanian, N. ^{[1
]}

Kasymjanova, G. ^{[3
]}

Proulx-Rocray, F. ^{[4
]}

Chan, S. ^{[5
]}

Richardson, M. ^{[6
]}

Brown, M. C.

Patel, D.

Dean, M. L. ^{[7
]}

Navani, V. ^{[7
]}

Moore, E.

Carvery, L. ^{[2
]}

Yan, E.

Cleary-Gosine, J. ^{[2
]}

Gibson, A. J. ^{[7
]}

Hubley, L. ^{[2
]}

Balaratnam, K. ^{[1
]}

Ngo, T. ^{[2
]}

Gill, A. ^{[9
]}

Black, M. ^{[10
]}

Sacher, A. ^{[1
]}

Bradbury, P. A. ^{[1
]}

Shepherd, F. ^{[1
]}

Leighl, N. ^{[1
]}

Cheema, P. ^{[9
]}

Kuruvilla, S. ^{[10
]}

Agulnik, J. ^{[3
]}

Banerji, S. ^{[8
]}

Juergens, R. ^{[5
]}

Blais, N.

Cheung, W. ^{[7
]}

Wheatley-Price, P. ^{[6
]}

Liu, G. ^{[1
]}

Snow, S. ^{[2
]}

机构：

[1] UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] QEII Hlth Sci Ctr, Halifax, NS, Canada

[3] Jewish Gen Hosp, Montreal, PQ, Canada

[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[5] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada

[6] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada

[7] Tom Baker Canc Clin, Calgary, AB, Canada

[8] CancerCare Manitoba Res Inst, Winnipeg, MB, Canada

[9] William Osler Hlth Syst, Brampton Civic Hosp, Brampton, ON, Canada

[10] London Hlth Sci Ctr, London, ON, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

KRAS G12C; Advanced NSCLC; Real-World Data;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP12.03-02

引用

页码：S680 / S680

页数：1

共 50 条

[1] Prognostic implication of KRAS G12C mutation in a real-world KRAS mutated stage IV NSCLC cohort treated with immunotherapy in the Netherlands
Noordhof, Anneloes L.
Swart, Esther M.
Damhuis, Ronald A. M.
Hendriks, Lizza E. L.
Kunst, Peter W. A.
Aarts, Mieke J.
Van Geffen, Wouter H.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[2] Distant Metastasis Pattern and Baseline Clinicopathological Features from a Real-World KRAS G12C Mutant Cohort of Advanced NSCLC Patients
Mollica, L.
Intagliata, S.
Bonomi, L.
Ghilardi, L.
Morotti, D.
Ghirardi, G.
Antelmi, E.
Gianatti, A.
Carioli, G.
Muglia, R.
Marra, P.
Raimondi, F.
Ciaravino, G.
Di Marco, F.
Sironi, S.
Tondini, C. A.
Bettini, A. C.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S495 - S496
[3] Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
Griesinger, F.
Eberhardt, W.
Hoffknecht, P.
Metzenmacher, M.
Wehler, T.
Kokowski, K.
Alt, J.
Schuette, W.
Jaenicke, M.
Fleitz, A.
Zacharias, S.
Hipper, A.
Buller, M.
Weichert, W.
Groschek, M.
von der Heyde, E.
Rauh, J.
Dechow, T.
Sebastian, M.
Thomas, M.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 135 - 135
[4] Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
Noordhof, Anneloes L.
Swart, Esther M.
Damhuis, Ronald A. M.
Hendriks, Lizza E. L.
Kunst, Peter W. A.
Aarts, Mieke J.
van Geffen, Wouter H.
JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (09):
[5] Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
Griesinger, F.
Eberhardt, W. E. E.
Hoffknecht, P.
Metzenmacher, M.
Wehler, T.
Kokowski, K.
Alt, J.
Schuette, W.
Jaenicke, M.
Fleitz, A.
Zacharias, S.
Hipper, A.
Buller, M.
Weichert, W.
Groschek, M.
von der Heyde, E.
Rauh, J.
Dechow, T.
Sebastian, M.
Thomas, M.
ANNALS OF ONCOLOGY, 2020, 31 : S872 - S872
[6] Real-world treatment pattern and clinical outcome in Chinese NSCLC patients with KRAS G12C mutation
Shen, L.
Song, Z.
Yin, Y.
Lei, Y.
Lu, S.
ANNALS OF ONCOLOGY, 2024, 35
[7] The Canadian Small Cell Lung Cancer Database (CASCaDe): A Multi-Institutional Real-World Evidence Collaboration
Moore, S.
Agulnik, J.
Bebb, G.
Dawe, D.
Elegbede, A.
Fung, A.
Ho, C.
Liu, G.
Lok, B.
Snow, S.
Wheatley-Price, P.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1189 - S1189
[8] The Canadian Small Cell Lung Cancer Database (CASCADE): Results from a Multi-Institutional Real-World Evidence Collaboration
Moore, S. M.
Zhan, L. J.
Liu, G.
Rittberg, R.
Patel, D.
Chowdhury, D.
Leung, B.
Cheng, S.
Mckinnon, M.
Khan, K.
Agulnik, J.
Fung, A. S.
Cheung, W. Y.
Snow, S.
Dawe, D.
Cohen, V.
Yan, M.
Ho, C.
Lok, B. H.
Wheatley-Price, P.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S244 - S244
[9] Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation
Waterhouse, David M.
Rothschild, Sacha
Dooms, Christophe
Mennecier, Bertrand
Bozorgmehr, Farastuk
Majem, Margarita
Heuvel, Michel H. van den
Linardou, Helena
Cho, Byoung Chul
Roberts-Thomson, Rachel
Tanaka, Kentaro
Blais, Normand
Schvartsman, Gustavo
Hansen, Karin Holmskov
Chmielewska, Izabela
Forster, Martin D.
Giannopoulou, Christina
Stollenwerk, Bjorn
Obiozor, Cynthia C.
Wang, Yang
Novello, Silvia
LUNG CANCER, 2024, 196
[10] Heterogeneity and prognostic diagnosis of KRAS-mutated population and KRAS G12C subtype among patients (pts) with advanced NSCLC (aNSCLC): A real-world study aided by machine learning approaches
Loong, H. H. F.
Liu, T.
Pattipaka, T.
Hong, R.
Smith, T. W.
Knoll, S. M.
Pretre, V.
Bitton, R. Caparica
Ye, F.
Farago, A.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1088 - S1088

← 1 2 3 4 5 →